Journal of Law and Medicine - COVID-19 as a Disruptor and a Catalyst for Change

/
Author updates
Content updates

The latest issue of the Journal of Law and Medicine includes a number of highly topical articles on COVID-19 including the General Editor's insightful editorial entitled "COVID-19 as a Disruptor and a Catalyst for Change."

According to Ian Freckelton AO QC, COVID-19 has "profoundly and pervasively disrupted the world’s health, economy, security and attitudes. It has caused us to rethink what is most important for us individually and collectively, what we must change to retain viability as a species and as a planet, and what values and public health infrastructures governments need to embrace to avoid the next pandemic."

COVID-19 related articles in the latest issue of the Journal of Law and Medicine include:

  • COVID-19 Denialism, Vaccine Scepticism and the Regulation of Health Practitioners.

  • COVID-19 Tests the Limits of Biodiversity Laws in a Health Crisis: Rethinking “Country of Origin” for Virus Access and Benefit-sharing.

  • The Impact of COVID-19 on Fertility Treatment in Australia.

  • Chasing Immunity: How Viable Is a Mandatory COVID-19 Vaccination Scheme for Australia?

  • Australian Medical Device Regulation during COVID-19: Has the Australian Regulatory Framework for Medical Devices Been Effective during the COVID-19 Pandemic?

For other content in this issue please visit: Journals Talk 

Tags
Content update
Journals
Medicine & Health
By Julia Moulding
Senior Content Manager

Julia works on a number of print and online products in the Analytical and Journals teams such as Expert Evidence and Indictable offences in Victoria, Quick on Costs, the Journal of law and Medicine and the Environmental and Planning Law Journal. Prior to working at Thomson Reuters, Julia was a practicing Solicitor in the UK.

Speak to a consultant

Can't find an answer to your question?
Contact our support team.

Contact us

Request training

Contact our team to arrange training.

Request training

Tell us what you think

We'd love to hear what you think
of our products and support.

Give feedback